EDC4 Knockout HeLa Polyclonal Cells are a CRISPR/Cas9-edited polyclonal knockout cell population targeting the EDC4 gene in HeLa cells. This heterogeneous pool of cells harbors disruptive mutations at the EDC4 locus, enabling loss-of-function studies without clonal selection artifacts. The polyclonal format reflects population-level gene inactivation, suitable for investigating EDC4’s scaffold role in mRNA decapping and its impacts on gene regulation.
The parental HeLa line is an immortalized epithelial cell line derived from a cervical adenocarcinoma, widely used for viral infection, cancer biology, and gene regulation studies. Its robust proliferation, ease of genetic manipulation, and well-characterized transcriptome make it an ideal host for generating knockout models. The epithelial adenocarcinoma background provides a physiologically relevant context for studying EDC4-dependent mRNA decay and its links to viral susceptibility and neurodevelopmental disorders.
EDC4 functions as an essential scaffold that integrates the catalytic subunit DCP2 and its activator DCP1A to form the active mRNA decapping complex, which removes the 5′ cap to trigger rapid 5′??3′ exonucleolytic decay. This process is activated by upstream signals such as cellular stress, viral double-stranded RNA, and the RNA-binding protein UPF1. EDC4 interacts with regulatory factors including DDX6, EDC3, LSM14A, PATL1, and the CCR4-NOT component CNOT1, placing it at the nexus of mRNA degradation, nonsense-mediated decay, and stress granule/P-body dynamics. Consequently, EDC4 disruption stabilizes specific transcripts and alters post-transcriptional gene silencing.
In HeLa cervical adenocarcinoma cells, EDC4 knockout provides a powerful tool to interrogate how dysregulated mRNA turnover contributes to cancer biology and host?Cpathogen interactions. The model is particularly valuable for dissecting the role of mRNA decapping in antiviral responses, given EDC4’s activation by viral double-stranded RNA. Additionally, known associations with neurodevelopmental disorders enable exploration of post-transcriptional mechanisms in disease-relevant contexts when combined with differentiation protocols. The polyclonal nature reduces clonal bias, ensuring phenotypes are representative.
Research applications include western blotting for EDC4, RT-qPCR of target mRNAs, actinomycin D chase assays for mRNA half-life, RNA-seq, immunofluorescence to visualize P-bodies and stress granules, co-immunoprecipitation of the decapping complex, and viral replication assays. These cells facilitate screening for modulators of mRNA stability and mechanistic studies of post-transcriptional regulation. For further details and validation support, please contact Ascent Research.
